Monthly Archives: July 2016

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Into Whether the Sale of NetSuite Inc. to Oracle Corporation is Fair to Shareholders – N

NEW YORK, NY / ACCESSWIRE / July 28, 2016 / The following statement is being issued by Levi & Korsinsky, LLP:

To: All Persons or Entities who purchased NetSuite Inc. (“NetSuite”) (NYSE: N) stock prior to July 28, 2016.

You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of NetSuite to Oracle Corporation (NYSE: ORCL) for $109.00 per share. To learn more about the action and your rights, go to: http://zlk.9nl.com/netsuite-n or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut, California, and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street – 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 442965

WellStar Energy Corp. Enters into $12,000,000 Letter of Intent to Acquire Operated Oil and Gas Assets in Alberta, Canada

CALGARY, AB / ACCESSWIRE / July 28, 2016 / WELLSTAR ENERGY CORP. (TSXV: WSE) (the “Company”), advises that the Company has entered into a Letter of Intent dated as of July 27, 2016 (the “LOI”) in connection with the acquisition of certain oil & gas assets located in East Central Alberta (the “Assets”) from an arm’s length vendor (the “Acquisition”). Pursuant to the terms of the LOI, the Company will acquire the Assets in consideration for a net purchase price of $12,000,000 including aggregate cash payments of $8,000,000 and the issuance of $4,000,000 of common shares of the Company at a deemed price of $0.50 per share.

The Assets encompass 212,997 gross (147,576 net) acres of operated and non-operated working interests in East Central Alberta producing approximately 700 barrels of oil equivalent (“BOE”) per day.

WellStar president and CEO Andrew H. Rees stated “This acquisition represents a clear path forward for the Company to excel through the current challenging resource price environment.” He commented further that “The Assets, based on vendor supplied third party engineering, while not reflecting recent production gains, contain approximately 2.68 million BOE in total proved reserves with a net present value discounted at 10 percent of approximately $22.5 million. Additionally, WellStar’s technical team believes there is significant upside to increase production from current levels.”

The Company will further define the Assets in upcoming news releases.

The completion of the Acquisition is conditional upon, among other things, completion of due diligence, entering into a mutually acceptable definitive agreement by mid October, 2016; the Company securing suitable financing within the timeframe agreed to by the parties and obtaining all necessary regulatory approvals to the Acquisition, including the TSX Venture Exchange (the “TSX-V”).

For further information please contact Andrew H. Rees at (403) 919-7900.

ON BEHALF OF THE BOARD

(signed) “Andrew H. Rees”
Andrew H. Rees
President

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Except for historical information contained herein, this news release contains forward-looking statements that involve risks and uncertainties. Actual results may differ materially. Except as required pursuant to applicable securities laws, the Company will not update these forward-looking statements to reflect events or circumstances after the date hereof. More detailed information about potential factors that could affect financial results is included in the documents filed from time to time with the Canadian securities regulatory authorities by the Company.

THE FORWARD-LOOKING STATEMENTS CONTAINED IN THIS PRESS RELEASE PRESENT THE EXPECTATIONS OF THE COMPANY AS OF THE DATE HEREOF AND, ACCORDINGLY, IS SUBJECT TO CHANGE AFTER SUCH DATE. READERS ARE CAUTIONED NOT TO PLACE UNDUE RELIANCE ON FORWARD-LOOKING STATEMENTS.

BOE presentation:

Barrel (“bbl”) of oil equivalent (“boe”) amounts may be misleading particularly if used in isolation. All boe conversions in this report are calculated using a conversion of six thousand cubic feet of natural gas to one equivalent barrel of oil (6 mcf=1 bbl) and is based on an energy conversion method primarily applicable at the burner tip and does not represent a value equivalency at the well head.

SOURCE: Wellstar Energy Corp.

ReleaseID: 442961

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Insmed Incorporated and Reminds Investors with Losses to Contact the Firm

IRVINE, CA / ACCESSWIRE / July 28, 2016 / Khang & Khang LLP (the “Firm”) announces that a class action lawsuit was filed against Insmed Incorporated (“Insmed” or the “Company”) (NASDAQ: INSM). Investors who purchased or otherwise acquired shares between March 18, 2013 and June 8, 2016 inclusive (the “Class Period”), are encouraged to contact the Firm prior to the
September 13, 2016 lead plaintiff motion deadline.

If you purchased shares of Insmed during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

According to the Complaint, the Company made false and/or misleading statements and/or failed to disclose that: the data on which Insmed’s European marketing authorization application relied on for its lead product candidate for the treatment of NTM lung disease, Arikayce, was not likely to support approval by the European Medicines Agency (“EMA”); Arikayce’s approval by the EMA for the treatment of NTM lung disease and subsequent commercialization in Europe were thus less likely than the Company had led investors to believe; and as a result of the above, Insmed’s public statements were materially false and misleading at all relevant times.

If you wish to learn more about this lawsuit, or if you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contacts

Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 442960

CPA24x7 A New Affiliate Network Launched Online With Flexible Products And Payouts

Team CPA24x7 visions to show transparency with its service and visions to enhance the reach of affiliate marketing in an more exclusive style.

New York, United State – July 28, 2016 /MarketersMedia/ —

The chief operating officer of CPA 24X7 LLC have just made an announcement regarding the launch of their brand new affiliate group: http://cpa24x7.com/. As per the narrations of COO, this new website is all meant to deliver excellent customer service for all categories of advertisers and affiliates.

The well supportive team has a lot expectation from market and even hope this new brand would all describe about their way of operation. The new website uses up to date layout and has better performing design module.

“We lead in market with excellent performance marketing channel and would continue to groom our identity from time to time”, said one of its spokesperson.

“The network aimed to establish a mutual connection with its advertisers and affiliates, to provide excellent services on requirement. Having an interrogation with few advertisers group and network teams a conclusion was made where we could even deliver better opportunities and create a positive bonding for long terms”.

Unlike other networks, CPA24X7 operates on consistent basis willing to make weekly payouts, make offers live on customers demand.

Keeping the identity of network confidential and private was all meant to stop the fraudulent activities and make best utilization of resources towards advertiser and affiliate group.

“Affiliates who have never been to this business even end up in generating profit”.

Lastly, soon every new user would be provided a tutorial sessions with step by step instructions, after they have signed up. Users would experience newer innovations from time to time with no hassles.

For more information, please visit http://cpa24x7.com/

Contact Info:
Name: Abraham
Organization: CPA24X7

Source: http://marketersmedia.com/cpa24x7-a-new-affiliate-network-launched-online-with-flexible-products-and-payouts/124731

Release ID: 124731

Levulinic Acid Market is Anticipated to have Significant Growth by 2020 Globally: Hexa Research

“Levulinic acid” demand for agriculture applications and other pesticides is expected to grow at a CAGR of 6% from 2014 to 2020. Levulinic acid demand for pharmaceutical applications is expected to grow at a CAGR of 5.4% from 2014 to 2020.

Felton, United States – July 28, 2016 /MarketersMedia/ —

Market research report on Levulinic Acid market by Hexa Research provides a clear picture about the worldwide development of the Levulinic Acid industry and recent key trends based on detailed statistical analysis. This new report provides latest market data, including market estimate and forecast by application and product on a regional basis for historic years of 2012 and 2013 with forecast up to 2020.

This report is an invaluable resource for industry executives looking for key market data in readily available and clearly presented graphs and tables. Major regional markets covered in this report include North America, Europe, Asia Pacific and Rest of the world.

Access Detail Report with TOC @
https://www.hexaresearch.com/research-report/levulinic-acid-industry/

Additionally, the Levulinic Acid market report includes comprehensive industry landscape, with market dynamics, drivers, restraints, opportunities and critical success factors. The Levulinic Acid market report analyzes major companies dealing in this market and provides company market share analysis. The report also contains detailed profiles of key market players with product benchmarking and company revenue analysis.

The report firstly provides market segmentation, current market scenario, growth prospects and value chain analysis. Then the report deeply analyzes the Levulinic Acid market conditions that include growth feasibility analysis, Porter’s five force analysis, PESTEL Analysis and market driver impact analysis. The growth feasibility analysis points out key areas in this market that deserve the most attention from market participants.

Overall, it is a comprehensive research report on the Global Levulinic Acid market; Hexa research is thankful to industry experts related to Levulinic Acid market for their valuable feedback and opinion during research compilation process.

For Enquiry before Purchasing the Report Click below Link
https://www.hexaresearch.com/inquiry-before-buying/51

Reasons to Buy This Report

• Find out global Levulinic Acid Market size, growth rate and forecast to 2020
• Key drivers and restraints of global Levulinic Acid Market
• Key opportunities in the Levulinic Acid Market
• Detailed regional estimates and forecast by application (North America, Europe, Asia Pacific, and Row) of global Levulinic Acid Market
• Competitive landscape, with Levulinic Acid Market company market share and detailed profiles of key market players

Browse More Related Reports on ” Renewable Chemicals “
https://www.hexaresearch.com/research-category/renewable-chemicals-industry

Table of Contents

Chapter 1 Executive Summary
Chapter 2 Levulinic Acid Industry Outlook
Chapter 3 Levulinic Acid Application Outlook
Chapter 4 Levulinic Acid Regional Outlook
Chapter 5 Levulinic Acid Competitive Landscape
Chapter 6 Methodology and Scope

About Us:
Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

For more information, please visit https://www.hexaresearch.com/research-report/levulinic-acid-industry/

Contact Info:
Name: Michelle
Organization: Hexa Research
Address: Felton Office Plaza 6265 Highway 9 Felton, California 95018
Phone: +1-800-489-3075

Source: http://marketersmedia.com/levulinic-acid-market-is-anticipated-to-have-significant-growth-by-2020-globally-hexa-research/125547

Release ID: 125547

Flurotelomers Market is Growing at a CAGR of 12.5% from 2014 to 2020 : Hexa Research

“Fluorotelomer acrylate” accounted for over 25% of the total demand in 2013 and is expected to gain above average growth rates. Rising importance of moisture resistance as a property in manufacturing industry is expected to amplify the demand for fluorotelomer acrylate owing to poses water repellency property.

Felton, United States – July 28, 2016 /MarketersMedia/ —

Global fluorotelomers market size is expected to reach 47.8 kilo tons by 2020. Increase in fire protecting systems demand owing to rising consumer awareness regarding safety is expected to drive fluorotelomers market. It is used as a stabilizing agent in fortification of fire fighting foams and aimed at minimizing the spread of fire and reduce smoke pollution.

Global fire protection systems (FPS) market was valued at USD 37.21 billion in 2013 and is expected to be USD 79.22 billion by 2020, growing at a CAGR of 11.4% from 2014 to 2020. Firefighting foams are used as a part of fire protection systems owing to their numerous advantages including rapid fire extinguishing property as well as protection to firemen.

Browse Detail report with TOC @
https://www.hexaresearch.com/research-report/flurotelomers-market

Increasing application scope in textile industry is expected to drive fluorotelomers market growth. Global textile production was 67.3 million tons in 2008 and reached 90.8 million tons by 2014.

It is used in treatment of textiles and medical textiles to increase the fabrics stain resistance cause by dust, solvents and chemicals. Telomers also provide protective surface finishing to textile products including surgical drapes and gowns, which provide protection to healthcare workers as well as patients against fluid-borne pathogens.

Over the past few years, textile production has witnessed drastic changes with a shift from developed economies of North America and Europe to developing markets of Asia Pacific owing to abundant raw material availability, cheap labor and low energy costs. Thus, its demand in textile applications is expected to be concentrated in Asia Pacific over the forecast period.

Presence of a stringent regulatory framework by EPA owing to adverse effects is expected to restrict production and usage of the raw materials such as vinylidene fluoride and tetrafluoroethylene. Developing fluorotelomers for niche applications such as metal plating, magazine paper and semiconductors is likely to open up new avenues for industry growth.

Application Overview

Fluorotelomer alcohol (FTOH) was the leading product segment with a market valuation exceeding USD 95 million in 2013. FTOH finds application as a chemical intermediate to manufacture fluoroorganic compounds, which are used in fabric stain repellants, paper coatings and surfactants.

Growing household sector in China, India and Middle East in light of rapid urbanization is expected to promote importance of carpets and surfactants. As a result, increasing importance of carpets and surfactants is anticipated to drive FTOH demand in the near future.

Fluorotelomer acrylate accounted for over 25% of the total demand in 2013 and is expected to gain above average growth rates. Rising importance of moisture resistance as a property in manufacturing industry is expected to amplify the demand for fluorotelomer acrylate owing to poses water repellency property.

Application Overview

Textile applications were the largest with a market valuation of over USD 100 million in 2013. Textile industry growth in India, China and Germany is expected to play an important role in driving fluorotelomer market growth in the near future.

Fire fighting foams was applications are expected to witness moderate gains with an estimated CAGR of over 11% up to 2020. Implementation of safety standards in manufacturing sectors such as oil & gas, mining, chemicals and automotive is expected to drive firefighting foams demand which is likely to promote fluorotelomer market growth.

Browse Related Reports on “Bulk Chemicals”

Argan Oil Market
https://www.hexaresearch.com/research-report/argan-oil-market

Automotive Coatings Market
https://www.hexaresearch.com/research-report/automotive-coatings-market

Competitive Market Share

Global industry is technology centric and highly regularized. Key manufacturers with fluorotelomers market share include DuPont, Wilshire Technologies, Fluoryx Inc., TCI Chemicals and Fluorous Technologies.

About Us:
Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

For more information, please visit https://www.hexaresearch.com/research-report/flurotelomers-market

Contact Info:
Name: Michelle
Organization: Hexa Research
Address: Felton Office Plaza 6265 Highway 9 Felton, California 95018
Phone: +1-800-489-3075

Source: http://marketersmedia.com/flurotelomers-market-is-growing-at-a-cagr-of-12-5-from-2014-to-2020-hexa-research/125554

Release ID: 125554

Parkinson’s Disease Therapeutics Market is Expected to Grow by Forecasted year 2019: Hexa Research

Incidence rates of “Parkinson’s disease” increase with aging and the fact that the percentage of the world’s population above the age of 65 years will increase from 7% in 2000 to 16% in 2050 will serve this market as a driver.

Felton, United States – July 28, 2016 /MarketersMedia/ —

Parkinson’s disease is a progressive movement disorder caused when dopamine producing nerve cells function irregularly. Dopamine regulates movement by sending signals to the brain and facilitates the smooth functioning of muscles. Some of the major symptoms of Parkinson’s disease include hand, arms or leg tremors, slow movement, problems associated with balancing and walking and stiff muscles. The fact that this disease is progressive in nature debilitates the patient’s condition and the later symptoms of Parkinson’s include trouble swallowing, constipation, fixed or blank expressions, dementia and speech disabilities.

Access Detail Report with TOC
https://www.hexaresearch.com/research-report/parkinson-disease-therapeutics-industry

The growing global prevalence of Parkinson’s disease is the primary growth driver of the global Parkinson’s disease therapeutics market owing to the fact the an increase in the prevalence of this disease directly widens the target population base for market players. According to the estimates of the WHO, the global prevalence of Parkinson’s disease was valued at over 10 million in 2012. Moreover, estimates suggest that almost one million Americans are currently living with this disease. Incidence rates of Parkinson’s disease increase with aging and the fact that the percentage of the world’s population above the age of 65 years will increase from 7% in 2000 to 16% in 2050 will serve this market as a driver. The introduction of alternative therapeutic options such as deep brain stimulation devices and the presence of high unmet medical needs in emerging markets such as India, China and Brazil will also have a positive impact on the market.

The overall therapeutic market for Parkinson’s disease can be segmented into four major categories namely drug therapy, deep brain stimulation devices, ablative neurosurgery and others. The drug therapy segment currently dominates the market in terms of revenue share. Patent expiration of key drugs such as Novartis or Orion Pharma’s Comtan/Stalevo/Comtess and Teva Pharmaceuticals or Lundbeck’s Azilect/Agilect will have a negative impact on this product segment’s growth. However, the presence of a strong pipeline is expected to offset the revenue loss due to patent expirations. Some of the major products currently in pipeline include Impax Laboratories/GlaxoSmithKline’s IPX-066, Kyowa Hakko Kirin’s adenosine A2A receptor antagonist istradefylline and Merck Serono/EMD Serono/Newron Pharmaceuticals’ MAO-B inhibitor safinamide.

For Enquiry before Purchasing the Report Click below Link
https://www.hexaresearch.com/inquiry-before-buying/25

This research report provides comprehensive market statistics and forecast for key segments, and provides complete industry landscape including drivers, restraints, regulatory scenario, technology trends and future opportunities. The report also provides detailed competitive landscape with company market share analysis and in-depth profiles of key market participants.

Key regional markets analyzed and reported in this study include:

• North America
• Europe
• Asia Pacific
• RoW

Critical elements of the report include:

• Industry dynamics
• Market challenges and opportunities
• Technology & regulatory trends
• Market estimate and forecast
• Regional trends
• Competitive trends

Why should you buy this report

• This report provides comprehensive analysis of the market including Porter’s and SWOT analysis
• Complete identification and analysis of key industry dynamics including drivers, restraints, raw material trends and buyer behavior
• The study provides technology landscape and regulatory trends for building strategy
• Global and regional market estimates and forecast on volume and revenue basis for multiple market segments
• Detailed competitive landscape of the market, with profiles of key companies

Browse Related Reports on “Healthcare”
https://www.hexaresearch.com/research-category/healthcare-industry

About Us:
Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

For more information, please visit https://www.hexaresearch.com/research-report/parkinson-disease-therapeutics-industry

Contact Info:
Name: Michelle
Organization: Hexa Research
Address: Felton Office Plaza 6265 Highway 9 Felton, California 95018
Phone: +1-800-489-3075

Source: http://marketersmedia.com/parkinsons-disease-therapeutics-market-is-expected-to-grow-by-forecasted-year-2019-hexa-research/125556

Release ID: 125556

Vaccine Development Strategies Market is Predicted to Grow at a CAGR of 12.0% Globally : Hexa Reports

The report provides in-depth analysis of the developing landscape for therapeutic vaccines, including recent activities of major pharmaceutical companies, insight into the challenges being faced by companies developing therapeutic vaccines and recommendations on clinical development strategies to overcome these potential obstacles and hurdles

Felton, United States – July 28, 2016 /MarketersMedia/ —

Vaccines are one of the most important healthcare advances and have saved millions of lives through immunizing against some of the most deadly diseases. With protection against a number of key viral and bacterial diseases now effectively generated, vaccine R&D is turning to areas of unmet need. Preventative vaccination in adults and against pathogens that affect the developing world is increasingly becoming a focus.

Research into therapeutic vaccination for patients already affected by a disease is also gathering pace. There are several different approaches to preventative vaccination, most of which have been effectively employed to reduce the incidence of certain diseases or, in some cases, eradicate them completely.

Access Detail Report with TOC @
http://www.hexareports.com/report/vaccine-development-strategies-refocusing-efforts-to-address-new-challenges/details

Scope
• This report providers readers with an understanding of the key developing trends in the vaccines market and how these are expected to impact on the overall competitive landscape, the major players and forecasted growth
• This report provides an overview of the preventative vaccines market, including insights into clinical development strategies, recommendations for maximizing potential for development of preventative vaccines and discussion about potential areas of growth in the near term
• The report provides in-depth analysis of the developing landscape for therapeutic vaccines, including recent activities of major pharmaceutical companies, insight into the challenges being faced by companies developing therapeutic vaccines and recommendations on clinical development strategies to overcome these potential obstacles and hurdles

Browse Latest Market Research Reports by Hexa Reports
http://www.hexareports.com/market-research-reports

• The report assesses the evolving competitive vaccines landscape, profiling the major pharmaceutical players and providing information into the emerging vaccines companies and assessing how the vaccines market is expected to develop in the short to medium term.
Key Reasons to Purchase
• The report will enable you to understand how key factors such as the emerging markets, new therapeutic targets and innovative technologies are becoming increasingly important to profitability and commercial return for vaccine companies as traditional targets and populations become satisfied
• Gain insights on the key challenges that exist to further vaccine development
• Compare considerations in both therapeutic and preventive vaccines markets

Request a Sample Copy of ” Vaccine Development Strategies Market ” report
http://www.hexareports.com/sample/89660

About Us:
Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

For more information, please visit http://www.hexareports.com/report/vaccine-development-strategies-refocusing-efforts-to-address-new-challenges/details

Contact Info:
Name: Ryan Shaw
Organization: Hexa Reports
Address: Felton Office Plaza 6265 Highway 9 Felton, California 95018
Phone: +1-800-489-3075

Source: http://marketersmedia.com/vaccine-development-strategies-market-is-predicted-to-grow-at-a-cagr-of-12-0-globally-hexa-reports/125562

Release ID: 125562

Geriatric Medicine Development is Predicted to have a Significant Growth in Healthcare Industry |Hexa Reports

The European Medicines Agency (EMA) introduced its “Geriatric Medicines” Strategy to ensure that the medical requirements of older people are identified earlier in the drug development process.

Felton, United States – July 28, 2016 /MarketersMedia/ —

More than 50% of prescriptions is written for people aged 65 years and older. Many older people suffer from co morbid conditions and one in three takes at least five drugs or more on a daily basis. This significantly increases the risk of Adverse Drug Events (ADEs) and hospitalization. Up to one third of emergency admissions in elderly people is drug-related.

Access Detail Report with TOC
http://www.hexareports.com/report/geriatric-medicine-development-carving-out-new-opportunities-to-treat-age-related-diseases/details

There remains a lack of clinical data to support prescription decisions as relatively few medicines have been clinically evaluated in age-appropriate patients. In addition, many drugs are not available in formulations that are suitable for the elderly, leading to non-compliance and lack of therapeutic efficacy. In 2011, the EMA introduced its Geriatric Medicines Strategy to ensure that the medical requirements of older people are identified earlier in the drug development process. In 2012, the ICH E7 guidelines were revised to include a greater focus on involving more geriatric patients in drug trials.

Scope

• Reviews the current regulatory landscape and helps sponsors to understand the potential impact of recent guidelines.
• Assesses the barriers to entry in geriatric medicines and identifies potential ways to overcome them and improve clinical decision making.
• Evaluates the importance of establishing Target Quality Product Profiles (TQPP) to help sponsors determine the target patient population earlier on in drug development.
• Identifies treatment gaps and commercial opportunities based on primary care real-time data and KOL insights.
• Analyses different strategies to develop age-appropriate medicines in niche therapeutic fields and discusses methods to encourage the smarter prescription of medicines.

Request a Sample Copy of ” Geriatric Medicine” report @
http://www.hexareports.com/sample/89659

Key Reasons to Purchase

• Utilize the insights from this study to analyze the barriers facing the geriatrics market
• Understand the impact of drug development in this market now and in the future
• Find out why regulators are paying more attention to unnecessary “exclusion criteria” and encouraging the inclusion of older people to ensure trials are age-appropriate and more representative of the real world setting.
• Assess the opportunities available for companies to develop age-appropriate dosages and formulations for existing drug classes that are currently widely associated with ADEs in the elderly as well as new therapeutic prospects.

Browse More Related Reports on ” Pharmaceuticals & Healthcare “
http://www.hexareports.com/category/pharmaceuticals-and-healthcare-market

About Us:
Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

For more information, please visit http://www.hexareports.com/report/geriatric-medicine-development-carving-out-new-opportunities-to-treat-age-related-diseases/details

Contact Info:
Name: Ryan Shaw
Organization: Hexa Reports
Address: Felton Office Plaza 6265 Highway 9 Felton, California 95018
Phone: +1-800-489-3075

Source: http://marketersmedia.com/geriatric-medicine-development-is-predicted-to-have-a-significant-growth-in-healthcare-industry-hexa-reports/125560

Release ID: 125560

Global Electronic Warfare (EW) Market is Predicted to Increase US$19 billion by 2025 : Research by Hexa Reports

“Global Electronic Warfare Systems Market” report offers a detailed analysis of the industry with market size forecasts covering the next ten years. This report will also analyze factors that influence demand for electronic warfare systems equipment, key market trends, and challenges faced by industry participants.

Felton, United States – July 28, 2016 /MarketersMedia/ —

Demand for electronic warfare systems is anticipated to be driven by rapid technological advancements in the domain and the growing need for intelligence, surveillance, and reconnaissance (ISR) capabilities in militaries globally. The electronic warfare systems market is expected to be dominated by North America, followed by Asia-Pacific and Europe. Modern warfare places a greater emphasis on information superiority and situational awareness, and this is expected to be a major factor driving spending in this sector.

Key Findings
• The global electronic warfare systems market is expected to be worth US$13.3 billion in 2015, and is expected increase to US$19 billion by 2025

• The North American region is estimated to account for the largest share of 41% in the global electronic warfare systems market, with the region accounting for a cumulative spending of US$72.1 billion over the forecast period. The region will be followed by Asia Pacific and Europe, with respective spending of US$51.6 billion and US$35.3 billion during 2015-2025

• In terms of segments, Electronic Protection and Electronic Warfare Support are expected to be the top two segments in the global electronic warfare systems market over the forecast period. The Electronic Protection segment is expected to account for 52.4% of the total market, Electronic Warfare Support segment is estimated to comprise 33.1%, and the Electronic Attack segment is estimated to account for 14.5% of the market

Request a Sample copy of ” Global Electronic Warfare (EW) Market ” report @
http://www.hexareports.com/sample/75635

Synopsis
• The Global Electronic Warfare Systems Market 2015-2025 report offers a detailed analysis of the industry with market size forecasts covering the next ten years. This report will also analyze factors that influence demand for electronic warfare systems equipment, key market trends, and challenges faced by industry participants. In particular, it provides an in-depth analysis of the following:

• Market size and drivers: detailed analysis during 2015-2025, including highlights of the demand drivers and growth stimulators. It also provides a snapshot of the spending and modernization patterns of different regions around the world

• Recent developments and industry challenges: insights into technological developments and a detailed analysis of the changing preferences of electronic warfare systems segments around the world. It also provides trends of the changing industry structure and the challenges faced by industry participants

• SWOT analysis: a study of the industry characteristics by determining the strengths, weaknesses, opportunities, and threats

• Regional highlights: study of the key markets in each region, providing an analysis of the key segments of the market that are expected to be in demand

• Major programs: details of the key programs in each segment, which are expected to be executed during 2015-2025

• Competitive landscape and strategic insights: analysis of the competitive landscape of the global market. It provides an overview of key players, together with information regarding key alliances, strategic initiatives, and financial analysis

Browse More Related Reports on ” Defense”
http://www.hexareports.com/category/defense-market

About Us:
Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

For more information, please visit http://www.hexareports.com/report/the-global-electronic-warfare-ew-market-2015-2025/details

Contact Info:
Name: Ryan Shaw
Organization: Hexa Reports
Address: Felton Office Plaza 6265 Highway 9 Felton, California 95018
Phone: +1-800-489-3075

Source: http://marketersmedia.com/global-electronic-warfare-ew-market-is-predicted-to-increase-us19-billion-by-2025-research-by-hexa-reports/125564

Release ID: 125564